Dermatology, Dermapathology · Grand Rapids, MI
NPI
1679573331
Since 2005
Specialty
Dermatology, Dermapathology
Code 207ND0900X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
833 Michigan St NE, Suite 102
Grand Rapids, MI, 49503
Phone (616) 459-8209
Medicare paid, 2024
$152K
3,398 services
Medicare patients, 2024
782
Average age 72
Drug cost, 2024
$6.8M
6,057 prescriptions
Company payments, 2025
$1,956
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marek A Stawiski was code 17003 (destruction skin lesion), 826 times for 213 patients. In total Marek A Stawiski billed 3,398 services in 61 codes, and Medicare paid $152K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 826 | 213 | $4.41 | $3,641 |
| 17000 Destruction Skin Lesion | Office | 346 | 294 | $37.77 | $13K |
| 88305 Surgical Pathology Examination | Office | 301 | 153 | $27.80 | $8,366 |
| 99212 Office E&M - Established | Office | 296 | 256 | $36.54 | $11K |
| 11102 Skin Biopsy | Office | 201 | 181 | $58.19 | $12K |
| 99213 Office E&M - Established | Office | 194 | 175 | $56.03 | $11K |
| 99214 Office E&M - Established | Office | 179 | 133 | $82.06 | $15K |
| 11103 Skin Biopsy | Office | 113 | 54 | $38.83 | $4,388 |
| 99202 Office E&M - New | Office | 88 | 88 | $38.66 | $3,402 |
| 96372 Injection Administration | Office | 85 | 18 | $8.01 | $681 |
| 99203 Office E&M - New | Office | 77 | 77 | $72.47 | $5,580 |
| 17110 Destruction Skin Lesion | Office | 66 | 59 | $75.89 | $5,009 |
| 17282 Destruction Skin Lesion | Office | 48 | 39 | $138.07 | $6,627 |
| 17004 Destruction Skin Lesion | Office | 46 | 36 | $118.81 | $5,465 |
| 17262 Destruction Skin Lesion | Office | 43 | 27 | $93.64 | $4,026 |
By year: 2022 $206K for 4,142 services; 2023 $147K for 3,439 services; 2024 $152K for 3,398 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 301 | 153 | $27.80 | $8,366 |
Medicare prescription drug claims, 2024
In 2024, the drug Marek A Stawiski prescribed most often to Medicare patients was Triamcinolone Acetonide, with 1,140 prescriptions and refills. In total Marek A Stawiski wrote 6,057 Medicare prescriptions that cost $6.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 1,140 | 1,355 | 609 | $13K |
| Hydrocortisone Generic | 749 | 864 | 369 | $7,168 |
| Hydroxyzine Hcl Generic | 433 | 542 | 146 | $3,374 |
| Clobetasol Propionate Generic | 420 | 525 | 206 | $14K |
| Dupixent Pen Dupilumab | 267 | 271 | 36 | $1.0M |
| Doxycycline Hyclate Generic | 260 | 395 | 98 | $5,160 |
| Mometasone Furoate Generic | 227 | 254 | 107 | $5,442 |
| Betamethasone Valerate Generic | 216 | 248 | 88 | $8,274 |
| Mupirocin Generic | 207 | 218 | 177 | $1,363 |
| Humira(Cf) Pen Adalimumab | 173 | 178 | 24 | $2.1M |
| Methotrexate Methotrexate Sodium | 170 | 413 | 53 | $4,802 |
| Minocycline Hcl Generic | 139 | 237 | 39 | $2,561 |
| Cephalexin Generic | 113 | 113 | 96 | $523 |
| Ketoconazole Generic | 111 | 171 | 44 | $2,246 |
| Clindamycin Phosphate Generic | 88 | 99 | 43 | $1,460 |
Brand drugs: 1,038 claims; generic drugs: 5,019 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marek A Stawiski $1,956 ($1,956 in general payments such as food, travel and fees) from 16 companies. The largest payer was Genzyme Corporation with $471.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 16 | $471 |
| Incyte Corporation INCY | 13 | $262 |
| Pfizer Inc. PFE | 21 | $236 |
| Novartis Pharmaceuticals Corporation NVS | 16 | $235 |
| Abbvie Inc. ABBV | 15 | $230 |
| Galderma Laboratories, L.P. GALD.SW | 5 | $97.98 |
| UCB, Inc. UCB.BR | 5 | $94.93 |
| Janssen Biotech, Inc. JNJ | 3 | $61.1 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $59.3 |
| Arcutis Biotherapeutics, Inc. ARQT | 3 | $52.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.